That is essential, due to the fact that the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has been an experimental process (biotech stock). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. This was an advancement practically nobody saw. However it's going to have profound implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (united arab emirates). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back possibly considerably prior to going greater - what is the legacy report predicting. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. But that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. angel investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous terrific private business on the verge of striking the general public markets And I've been dealing with a new way for you to invest even before these business go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to reserve your area totally free.
Emma Walsh here, managing editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (tech stock). And when it comes to tech investing, we leave it to the experts. The good news is, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing experts we understand (social media). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing exponential development and creating extraordinary opportunities for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown predictions 2021. But regardless of what numerous readers may believe, this is a pattern that's simply getting begun. Even though the COVID-19 pandemic interrupted supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (the legacy report prediction). Losing two months of manufacturing and sales actually impacts the number of 5G devices are sold in the calendar year. When you consider all of that, offering 250 million systems is amazing. More importantly, the hold-ups triggered by the pandemic produced a lots of suppressed need. Which need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown investor prediction. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually explained its 3 various stages.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Phase Three, 5G services start to be offered (jeff brown top biotech stock 2021). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage 3 by this summer. This starts something of a virtuous cycle: A lot of individuals don't truly appreciate the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be huge. Stepping away from 5G, the next important innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a similar concept however with our genetic code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche innovation that wasn't well understood. And during that time, there were truly just 3 business running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing unbelievable returns. This whole market is effectively a greenfield opportunity.
There's space for lots of companies to exist in this area. jeff brown biotech stocks. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or three more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can precisely anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is necessary because the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has actually been an experimental process. However now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however several drug treatments produced utilizing this innovation. This was among those advancements that practically no one discovered. But it's going to have extensive ramifications for treating illness. And, of course, there will be plenty of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back maybe considerably before going greater. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin - jeff brown top stock pick 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. brownstone research. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, however we might not independently verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to choose winning innovation stocks. He invested more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional viewpoint on the market. He's always on the hunt for brand-new chances, and he shares numerous of his best picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively predicted a few of the most significant economic events of the previous 20 years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it ideal whenever, but Jeff Brown's accurate forecasts have earned him legions of devoted followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research, a prominent monetary research publisher. Brownstone Research uses numerous research study services with a wide array of specializations - last year.
The company is also connected with Bonner & Partners, another well-respected research publisher - biotech stocks jeff brown. On its website, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the finest investment research study has not been available to private financiers. It has actually been generally reserved for investment banks, hedge funds, private equity, and high-net-worth clients. jeff bezos. The mission of Brownstone Research is to make that type of proprietary research study offered to any investors wanting to acquire an edge in the marketplaces. The goal is basic to deliver special and rewarding investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also functions as the firm's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout many of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. united arab emirates. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. second wave. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 innovative technologies: synthetic intelligence and electrical cars and trucks. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing short of the vehicle market's Holy Grail. As you understand, electrical lorries and self-driving car stocks have been huge this year, however the Wall Street machine has actually been big on buzz without much concrete outcome. In spite of a drastic boost in competitors over the past couple of years, Brown still believes Musk has the very best chance of putting all of it together.
tech might be the magic string that connects everything together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transport. Generally, this technology would enable you to rent out your car as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the automobile and press a button on an app that tells the car to "join the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a large portion of the earnings. It sounds outrageous, but it might be closed than you think.